Login

Financial Snapshot

Revenue
TTM
$1.189B
Gross Margin
TTM
55.21%
Net Income
TTM
$117.8M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
281.98%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$622.5M
Cash
2026 Q1
P/E
TTM
36.36
Free Cash Flow
TTM
$96.84M

Stock Price

Loading...
Market Cap: $4.2832 Billion

About Sotera Health Co

Sotera Health Co (NASDAQ: SHC) is a healthcare services company that provides outsourced sterilization, cobalt-60 isotope supply, and laboratory testing services for medical device, pharmaceutical, and food safety customers. Revenue comes from service fees charged under multi-year contracts across three segments: Sterigenics (contract sterilization), Nordion (cobalt-60 supply and gamma irradiation systems), and Nelson Labs (microbiological and analytical chemistry testing). Sterigenics competes globally with Applied Sterilization Technologies, a segment of STERIS plc, as well as smaller regional sterilization providers. More than 90% of Sterigenics revenues for the year ended December 31, 2025 were from customers under multi-year contracts, and no single customer accounted for more than 10% of total revenues. Sterigenics reported 100% renewal rates among its top ten customers for more than five consecutive years as of the FY2025 10-K filed February 24, 2026. Approximately 90% of Nordion revenues for the year ended December 31, 2025 were also from multi-year contracts. Nelson Labs offers over 900 microbiological and analytical chemistry tests plus fee-based advisory and regulatory consulting services.

Revenue model
Service fees under multi-year contracts for sterilization processing (Sterigenics), cobalt-60 isotope sales priced by radioactivity level in curies plus gamma irradiation system design and maintenance (Nordion), and per-test laboratory fees plus advisory service fees (Nelson Labs).
Products and services
Ethylene oxide sterilization, gamma irradiation sterilization, X-ray irradiation sterilization, NO2-based sterilization, cobalt-60 isotope supply (low specific activity and high specific activity), gamma irradiation system design and installation, microbiological testing, analytical chemistry testing, product development and validation testing, regulatory consulting, advisory services.
Customers and end markets
Medical device manufacturers, pharmaceutical companies, food safety producers, outsourced contract sterilizers, semiconductor manufacturers, the USPS, and in-house sterilizing manufacturers. End markets include single-use medical devices, prefilled syringes, drug-device combination products, custom implants, and food microbial reduction.
Value-chain role
Outsourced sterilization service provider and isotope supplier positioned between manufacturers and the point of clinical or commercial use. Vertically integrated through cobalt-60 production (Nordion) into sterilization services (Sterigenics) and independently operating laboratory testing and advisory services (Nelson Labs).
Geographic exposure
United States and international operations; Nordion processes cobalt-60 at its Ottawa facility and ships globally using a proprietary licensed container fleet. Filing identifies risks from operations in multiple jurisdictions but does not disclose a specific revenue breakdown by geography in the excerpts provided.
Competitors
Applied Sterilization Technologies (segment of STERIS plc)

Source: SEC 10-K, filed 2026-02-24

Industry: Services-Misc Health & Allied Services, NEC Peers: 10X Genomics Inc Adaptive Biotechnologies Corp Neogenomics Inc Azenta Inc Cytek Biosciences Inc Syneos Health, Inc. Medpace Holdings Inc Pacific Biosciences of California Inc Thermo Fisher Scientific Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support